Company
Kiniksa
Led by a team of distinguished life sciences leaders, Kiniksa is a global biopharmaceutical company that finds and delivers novel treatments for patients with a significant unmet need.
Also known as Kiniksa Pharmaceuticals International, plc
- Status
- IPOas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Lexington, MA, United States
- Founded
- 2015
- Customers
- patients with a significant unmet need
- Legal name
- Kiniksa Pharmaceuticals International, plc
- kiniksa.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 18 September 2026
About
Founded in 2015, Kiniksa Pharmaceuticals is a global biopharmaceutical company dedicated to advancing novel, transformative therapies for patients with unmet medical needs, with a focus on cardiovascular diseases.
Funding snapshot
- Total raised
- $251MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- IPO, $171M2018
Funding rounds
- IPO
- $171M2018, Company stated
- Series A
- $80M2015, Company stated
About the company
- Status notes
- Raises $170.7M in gross proceeds from IPO.
Products
- Other
- ARCALYST (rilonacept)
Loading relationship preview